#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13364	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2161	613.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1420	1420	C	757	C	717	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	665.4	0	.	n	.	0	T695C	SNP	695	695	T	1019	1019	C	723	C	690	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	665.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1661	1661	A	800	A,G	762,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	665.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2295	2295	C	808	C	746	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	665.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2369	2369	A	750	A	713	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3615	665.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2921	2921	C	764	C	723	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1838	folP	852	852	100.0	folP.l15.c17.ctg.1	1458	125.0	1	SNP	p	R228S	1	.	.	682	684	AGC	967	969	AGC	183;183;182	A;G;C,T	176;175;174,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4696	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3423	136.6	1	SNP	p	S91F	0	.	.	271	273	TCC	551	553	TCC	172;170;170	T;C;C	160;157;159	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4696	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3423	136.6	1	SNP	p	D95N	0	.	.	283	285	GAC	563	565	GAC	172;170;175	G;A,G;C	160;157,1;163	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4696	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3423	136.6	1	SNP	p	D95G	0	.	.	283	285	GAC	563	565	GAC	172;170;175	G;A,G;C	160;157,1;163	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1422	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1276	110.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	436	438	ACC	158;159;158	A;C;C	143;150;146	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1422	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1276	110.5	0	.	p	.	0	R44H	NONSYN	130	132	CGC	451	453	CAC	162;162;164	C;A;C	146;145;151	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1422	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1276	110.5	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	634	636	CAC	183;187;187	C;A;C	177;180;178	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1422	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1276	110.5	1	SNP	p	G45D	0	.	.	133	135	GGC	454	456	GGC	164;161;161	G;G;C	152;149;149	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	788	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	814	95.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	161.5	1	SNP	p	D86N	0	.	.	256	258	GAC	552	554	GAC	202;203;205	G;A;C	191;193;195	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	161.5	1	SNP	p	S87I	0	.	.	259	261	AGT	555	557	AGT	203;203;208	A;G;T	194;193;199	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	161.5	1	SNP	p	S87W	0	.	.	259	261	AGT	555	557	AGT	203;203;208	A;G;T	194;193;199	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	161.5	1	SNP	p	S87R	0	.	.	259	261	AGT	555	557	AGT	203;203;208	A;G;T	194;193;199	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2938	161.5	1	SNP	p	S88P	0	.	.	262	264	TCC	558	560	TCC	207;206;207	T;C;C	199;198;200	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3960	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2530	155.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1423	1425	GGC	198;196;195	G;G;C	184;183;180	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1216	1218	GCA	202;200;199	G;C;A	187;183;186	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1219	1221	ATC	200;201;204	A;T;C	189;187;194	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1231	1233	GTG	205;206;206	G;T;G,A	192;192;193,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1231	1233	GTG	205;206;206	G;T;G,A	192;192;193,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1735	1737	ACC	159;159;162	A;C;C	152;150;152	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1789	1791	GCG	168;168;170	G;C,G;G	157;129,1;147	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1789	1791	GCG	168;168;170	G;C,G;G	157;129,1;147	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1912	1914	GGT	148;148;149	G;G;T	143;142;144	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1921	1923	GGC	155;155;153	G;G;C	148;148;143	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3528	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2309	151.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1939	1941	CCG	135;136;132	C;C;G	103;124;108	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5002	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3138	158.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1705	1707	CTG	178;176;177	C;T;G	168;163;164	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2188	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1956	111.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	663	663	C	143	C	140	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1553	168.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	441	443	GTT	215;213;212	G,A;T,G;T	206,1;202,1;199	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1553	168.3	0	.	p	.	0	I75V	NONSYN	223	225	ATT	531	533	GTT	217;222;226	G;T;T	202;197;206	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1553	168.3	0	.	p	.	0	S89T	NONSYN	265	267	AGC	573	575	ACC	220;221;222	A;C;C	197;206;210	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1553	168.3	0	.	p	.	0	I98V	NONSYN	292	294	ATC	600	602	GTC	214;211;209	G;T;C	192;185;189	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1553	168.3	0	.	p	.	0	S217G	NONSYN	649	651	AGT	957	959	GGT	225;226;226	G;G;T	214;215;209	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1553	168.3	1	SNP	p	G120K	1	.	.	358	360	AAG	666	668	AAG	180;182;181	A;A;G	172;173;171	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1553	168.3	1	SNP	p	A121N	1	.	.	361	363	AAC	669	671	AAC	181;182;183	A;A;C	171;172;172	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1553	168.3	1	SNP	p	N121D	0	.	.	361	363	AAC	669	671	AAC	181;182;183	A;A;C	171;172;172	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9726	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4914	197.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2074	2076	AAT	216;217;221	A,C;A;T	206,2;207;211	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	964	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	900	105.9	1	SNP	p	V57M	1	.	.	169	171	ATG	433	435	ATG	187;191;193	A;T;G	180;183;185	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	168	94.05	tetM.l15.c4.ctg.1	170	2.4	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	5	7	ACG	1;2;2	A;C;G	1;2;2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	168	94.05	tetM.l15.c4.ctg.1	170	2.4	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	56	58	ATT	3;3;3	A;T;T	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	168	94.05	tetM.l15.c4.ctg.1	170	2.4	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	59	61	AGT	3;3;3	A;G;T	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	168	94.05	tetM.l15.c4.ctg.1	170	2.4	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	98	100	CTA	4;4;4	C;T;A	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	168	94.05	tetM.l15.c4.ctg.1	170	2.4	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	140	142	AAT	2;2;2	A;A;T	2;2;2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	557	99.1	tetM.l15.c4.ctg.2	599	3.2	0	.	p	.	0	T58S	NONSYN	172	174	ACA	211	213	TCA	3;4;4	T,A;C;A	0,2;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	557	99.1	tetM.l15.c4.ctg.2	599	3.2	0	.	p	.	0	M177T	NONSYN	529	531	ATG	568	570	ACG	2;2;2	A;C;G	2;2;2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	557	99.1	tetM.l15.c4.ctg.2	599	3.2	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	589	591	GAC	1;1;1	G;A;C	1;1;1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	188	91.49	tetM.l15.c4.ctg.4	188	3.2	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	53	55	TCA	5;5;5	T;C;A	4;4;4	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	188	91.49	tetM.l15.c4.ctg.4	188	3.2	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	77	79	ATG	4;4;4	A;T;G	4;4;4	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	226	99.56	tetM.l15.c4.ctg.5	379	3.7	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	68	70	GAA	3;3;3	G;A;A	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	241	100.0	tetM.l15.c4.ctg.6	241	3.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	194	97.42	tetM.l15.c4.ctg.7	195	2.6	0	.	p	.	0	L194S	NONSYN	580	582	TTA	5	7	TCA	1;1;1	T;C;A	1;1;1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	194	97.42	tetM.l15.c4.ctg.7	195	2.6	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	161	163	CCG	1;1;1	C;C;G	1;1;1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	70	tetM	1920	194	97.42	tetM.l15.c4.ctg.7	195	2.6	0	.	p	.	0	K252N	NONSYN	754	756	AAA	179	181	AAT	1;1;1	A;A;T	1;1;1	.	Tetracycline resistance
